Tenax Therapeutics Without Revenue Gets Soaring Stock (NASDAQ: TENX)

Yesterday NASDAQ: TENX climbed 0.69% to $1.45. Buyers increased daily trading volume to 1,427,457 shares that are four times bigger than the average daily 324,664 shares.

A couple of weeks ago, Tenax Therapeutics revealed Q1 2020 financial report which is similar to the previous quarter results with negative net income and unstable operating expenses. Through several years the company has not made revenue since its products and services have been under development.

The company purely depends on external financing while its market value of $13.367 million is firmly overvalued as compared to its actual $3,419,000. As everyone noticed the company is not producing anything yet its EPS (12 months) stands at $-1.404.

Alex Krakowsky

Editor in Chief.Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life